The Neuropathic Pain Market, valued at USD 7.2 billion in 2025, is projected to reach USD 15.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 10.3%. This expansion reflects rising chronic conditions like diabetes and an aging global population, alongside a push for innovative non-opioid treatments. Browse Detailed Summary of Research Report @...